Stewart Garneau
Hematology & Oncology · Moline, ILNPI 1336132943
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $815 of the $973 with a category attached, or 83.7%. 22 manufacturers reported payments, led by AstraZeneca at 26.0% of the total. Reporting peaked in 2019 at $658 and has fallen 86.5% since, to $89 in 2022. That places this record below the midpoint for hematology & oncology clinicians in IL, where the typical reported total is $2,365.
Across 44 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$253
- Genentech USA, Inc.$143
- Novartis$105
- E.r. Squibb & Sons, L.L.C.$64
- Exelixis Inc.$46
- Amgen$42
- plus $321 from 16 others
What the payments were for
- Food & beverage$81584%
- Education$15816%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 6 | $253 |
| Genentech USA, Inc. | 3 | $143 |
| Novartis | 6 | $105 |
| E.r. Squibb & Sons, L.L.C. | 4 | $64 |
| Exelixis Inc. | 2 | $46 |
| Amgen | 2 | $42 |
| Merck | 2 | $38 |
| Agios Pharmaceuticals, Inc. | 2 | $36 |
| Johnson & Johnson | 2 | $28 |
| Pfizer | 2 | $28 |
| Lilly USA, LLC | 2 | $28 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Tesaro, Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Clovis Oncology, Inc. | 1 | $12 |
| Array Biopharma Inc | 1 | $12 |
| Mylan Institutional Inc. | 1 | $12 |
| Gilead | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$973 in reported general payments places this provider in the 35th percentile of 580 hematology & oncology providers in Illinois.
Other hematology & oncology in Moline
- Mohamad Khair KhasawnehMaywood$998K
- Michael BishopChicago$974K
- Jamile ShammoChicago$910K
- John BerryBerwyn$687K
- Young Kwang ChaeChicago$563K
- Irfan MirzaChicago$544K
- Marina GarassinoChicago$397K
- Tulio RodriguezZion$337K
- Chih-Yi LiaoChicago$317K
- Gary KayElk Grove Village$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.